Fri Aug 29 11:23:15 SGT 2014  
SINGAPORE
PIMPLE™
    Pimple treatment, Singapore (SG)

Pimple treatment, Singapore (SG)

Summary

Pimple treatment, Singapore (SG) @singaporepimple_com: Acne, pimples, zits, and oily skin treatment, prevention clinic, Singapore - With Beauty SG & Shim Clinic skin care products and Neostrata® chemical peels.

Description

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Pimple treatment, Singapore (SG)
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

References


Latest News

Want a beautiful back? All you need is aspirin and yoghurt! 
Thu, 28 Aug 2014 02:18:46 +0100 | the Mail online | Health
An elegant back may have been the ultimate accessory at this week’s Emmy Awards, but if you’re plagued by back acne or ‘bacne’ — you won’t be so keen to show yours off. (Source: the Mail online | Health)

ACTIOGEN ACNE DOTS TREATMENT (Acne Treatment) Patch [Actiogen Corp]
Wed, 27 Aug 2014 05:00:00 +0100 | DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)
Updated Date: Aug 27, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck
Mon, 25 Aug 2014 00:00:00 +0100 | Annals of Oncology
Conclusion

Mayo Clinic Radio: Back-To-School
Mon, 25 Aug 2014 00:00:00 +0100 | News from Mayo Clinic
For many students this is back-to-school time!  On the next Mayo Clinic Radio, Saturday, August 30 at 9 a.m. CT, four physicians will join us and share important information related to sending your student back to class.  Noelle Larson, M.D., will discuss scoliosis and finding the correct sized backpack.  Dawn Davis, M.D., will talk about acne, [...] (Source: News from Mayo Clinic)

Budesonide for maintenance of remission in Crohn's disease.
Thu, 21 Aug 2014 00:00:00 +0100 | Cochrane Database of Systematic Reviews
CONCLUSIONS: These data suggest budesonide is not effective for maintenance of remission in CD, particularly when used beyond three months following induction of remission. Budesonide does have minor benefits in terms of lower CDAI scores and longer time to relapse of disease. However, these benefits are offset by higher treatment-related adverse event rates and more frequent adrenocorticoid suppression in patients receiving budesonide.

UCSF study: Hand-wringing over hospital handwashing
Tue, 19 Aug 2014 21:12:00 +0100 | bizjournals.com Health Care:Biotechnology headlines
Handwashing using antibacterial soap may expose doctors, nurses and other hospital staffers to "significant and potentially unsafe levels of triclosan," a commonly used chemical that's under review by the U.S. Food and Drug Administration, according to a clinical study led by researchers at UC San Francisco.

Systemic exposure of topical erythromycin in comparison to oral administration and the effect on CYP3A activity
Tue, 19 Aug 2014 00:00:00 +0100 | British Journal of Clinical Pharmacology
ConclusionTopical erythromycin did not cause clinically relevant CYP3A alterations although low systemic availability of erythromycin was observed. This supports the assumption that treatment with topical erythromycin is not critical in terms of CYP3A inhibition. Furthermore, substantial non‐linearity of erythromycin pharmacokinetics after 2 different oral doses was observed possibly due to autoinhibition. (Source: British Journal of Clinical Pharmacology)

Pathogenesis and Treatment of Acne and Rosacea
Fri, 15 Aug 2014 10:25:38 +0100 | Springer Medicine titles
(Source: Springer Medicine titles)

Topical antimicrobial acne treatment tolerability: A meaningful factor in treatment adherence?
Thu, 14 Aug 2014 09:54:40 +0100 | Journal of the American Academy of Dermatology
Adherence to dermatologic treatment is estimated to range from 55% to 66%1 but is as low as 45% for daily application of topical antimicrobial acne treatments.2 Poor adherence may be the most important factor in acne treatment failure.3 Dogma suggests that irritation and poor tolerability reduce patients' adherence to treatment. Is there evidence to support this dogma? (Source: Journal of the American Academy of Dermatology)

Self medicated antibiotics in Bangladesh: a cross-sectional health survey conducted in the Rajshahi City
Thu, 14 Aug 2014 00:00:00 +0100 | BMC Public Health - Latest articles
Conclusions: